Visual perseveration: a new side effect of maprotiline.
OBJECTIVE
The aim of this paper is to describe a case of visual perseveration including palinopsia during maprotiline therapy.


METHODS
A single case report.


RESULTS
The patient, a 56-year-old depressive man, suffered from visual perseveration during maprotiline therapy. The visual perseveration was dose-related and disappeared with reduction and cessation of the therapy.


CONCLUSIONS
The present findings suggest that maprotiline can induce visual perseveration including palinopsia in some patients.
Hori
H
H
Department of Psychiatry, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
Terao
T
T
Nakamura
J
J
D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects* / Q000494:pharmacology; D001921:Brain / Q000187:drug effects / Q000503:physiopathology; D003863:Depression / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D004569:Electroencephalography; D006801:Humans; D008297:Male; D008376:Maprotiline / Q000009:adverse effects* / Q000494:pharmacology; D008875:Middle Aged; D010468:Perceptual Disorders / Q000139:chemically induced*; D014796:Visual Perception
D018687:Antidepressive Agents, Second-Generation; D008376:Maprotiline